Please use this identifier to cite or link to this item:
http://hdl.handle.net/123456789/43302Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Tercatin, Rossella | - |
| dc.date.accessioned | 2021-12-02T06:55:25Z | - |
| dc.date.available | 2021-12-02T06:55:25Z | - |
| dc.date.issued | 2021-12-02 | - |
| dc.identifier.uri | http://hdl.handle.net/123456789/43302 | - |
| dc.description | page 4 | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | The Jerusalem Post | en_US |
| dc.subject | Vaccination | en_US |
| dc.subject | Virus | en_US |
| dc.title | Vaccine efficacy v. Omicron - what we know | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | Newspaper Clippings | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| December 2, 2021 pg 4.pdf | Vaccine efficacy v. Omicron - what we know | 139.98 kB | Adobe PDF | View/Open |
Items in QC LIBROS are protected by copyright, with all rights reserved, unless otherwise indicated.